Tenon Medical Anticipates Revenue Growth Despite Projected Loss Tenon Medical is set to report a 79.5% jump in revenue for Q4 2024, reaching $1.451 million, though analysts expect a $2.54 per share loss. Despite challenges, the company holds a "buy" rating and a $10 median price target, significantly higher than its current $1.12 stock price.12